干细胞市场规模即将达到 $15.63 十亿 2025 | 复合年增长率: 9.2%

全球干细胞市场预计将达到156.3亿美元 2025, 年复合增长率为 9.2%, 根据 Grand View Research 的一份新报告, 公司. Augmentation in research studies that aim at broadening the utility scope of associated products is anticipated to drive the market growth. These research projects have opened the possibility of implementation of several clinical applications of these cells, thereby impacting disease-modifying treatments.

Scientists are engaged in discovering novel methods to create human stem cells. This is to address the increasing demand for stem cell production for potential investigation in disease management. This factor is certainly expected to accelerate the development of regenerative medicine, thus driving industrial growth.

而且, cellular therapies are recognized as the next major advancements in transforming healthcare. Firms are expanding their cellular therapy portfolio, understanding the future potential of this arena in the treatment of Parkinson’s disease, 类型 1 糖尿病, 脊髓损伤, 阿尔茨海默氏病, and others.

三月 2016, Scientists at Michigan State University unveiled new kind of cells “induced XEN cells” from a cellular trash pile. This discovery is expected to drive advancements in regenerative medicine. Such discoveries are anticipated to bolster research and sales in this market over the forecast period.

 

Further key findings from the report suggest:

成体干细胞

dominated the market and is expected to maintain its dominance. This can be attributed to the several factors such as lower rejection rates, long term renewal property, and no ethical concerns associated with their usage

Application wise regenerative medicine is estimated to hold the substantial share of the revenue

Presence of significant number pipeline projects for regenerative medicine is expected to fuel growth in the market

此外, exploding research projects have driven the need of harvesting techniques, thereby propelling progress of acquisition technology

Increased R&D activities and huge funds granted by funding bodies to advance cellular research in the U.S. have resulted into the large share of North America

Extensive research carried out in Singapore and Japan is anticipated to drive progress with lucrative avenues

Advanced Cell Technology Inc, Osiris Therapeutics Inc, Celgene Corporation, BIOTIME, INC., Cynata, and STEMCELL Technologies Inc., are some of the major companies operating in this market

A number of stem cells companies

are engaged in seeking investment from overseas organizations and also developing partnerships with the pharmaceutical organizations

Grand View Research has segmented the global stem cells market on the basis of product, application, technology, 治疗, and region:

Stem Cell Product Outlook (Revenue, USD Billion, 2014 – 2025)

Adult Stem Cells

Neuronal Stem Cells

造血干细胞

间充质干细胞

Umbilical Cord Stem Cells

Others

Human Embryonic Stem Cells

诱导多能干细胞

Very Small Embryonic Like Stem Cells

Stem Cell Application Outlook (Revenue, USD Billion, 2014 – 2025)

再生医学

Neurology

骨科

Oncology

Hematology

Cardiovascular and Myocardial Infraction

Injuries

糖尿病

Liver Disorder

Incontinence

Others

Drug Discovery and Development

Stem Cell Technology Outlook (Revenue, USD Billion, 2014 – 2025)

Cell Acquisition

Bone Marrow Harvest

Umbilical Blood Cord

Apheresis

Cell Production

Therapeutic Cloning

In-vitro Fertilization

Cell Culture

Isolation

Cryopreservation

Expansion and Sub-Culture

干细胞治疗 Outlook (Revenue, USD Billion, 2014 – 2025)

自体 干细胞治疗

同种异体 干细胞治疗

 

To request this report, please contact Dr Eugene Zadorin

( eugene.zadorin@nbscience.com )